VESPER-2 VESPER-2 was a randomized, multicenter, double-blind, 28-week placebo-controlled trial that investigated the efficacy and safety of weekly berobenatide doses in adults with obesity or overweight and type 2 diabetes
This damages the cellular structure of the skin and stimulates the production of superoxide, a compound that causes hair follicles to stop growing and enter the shedding phase
By improving insulin sensitivity and promoting weight loss, GLP-1 medications can help restore more regular ovulation and improve the underlying metabolic environment
Some pharmacies or healthcare programs may offer discounts or assistance for those without insurance
ZenovaMD reviews, assesses your needs, and personalizes your plan
Premium Quality: Designed to meet the highest standards of cleanliness and functionality